Transaction DateRecipientSharesTypePriceValue
16th November 2020Theodor Krantz14,670Exercise of derivative$10.53$154,438.43
16th November 2020Theodor Krantz14,670Open or private sale$72.13$1,058,189.64
13th November 2020Theodor Krantz330Open or private sale$72.00$23,760.00
13th November 2020Theodor Krantz330Exercise of derivative$10.53$3,474.08
11th November 2020Robert Willett26,384Open or private sale$71.85$1,895,619.16
11th November 2020Robert Willett26,384Exercise of derivative$20.20$532,824.88
10th November 2020Robert Willett53,616Open or private sale$70.05$3,755,586.34
10th November 2020Robert Willett53,616Exercise of derivative$20.20$1,082,775.12
9th November 2020Robert Willett80,000Open or private sale$71.44$5,715,208.00
9th November 2020Robert Willett80,000Exercise of derivative$20.20$1,615,600.00
Cognex
Cognex logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.


Cognex was founded by Robert J. Shillman, William Silver, and Marilyn Matz in 1981 and is headquartered in Natick, MA. Cognex provides machine vision products that capture and analyze visual information.


Ticker: CGNX
Sector: Electronic Technology
Industry: Electronic Equipment/Instruments
SEC Central Index Key (CIK): 851205
Employees: 2267
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $286 M (0%)
Inventory, Net: $53 M (0%)
Assets, Current: $646 M (6%)
Property, Plant and Equipment, Net: $84 M (-6%)
Other Assets, Noncurrent: $8 M (37%)
Assets: $2 B (2%)
Accounts Payable, Current: $18 M (0%)
Accrued Liabilities, Current: $66 M (26%)
Liabilities, Current: $145 M (20%)
Other Liabilities, Noncurrent: $5 M (111%)
Liabilities: $558 M (5%)
Common Stock, Shares, Issued: $173 Th (0%)
Additional Paid in Capital, Common Stock: $710 M (11%)
Retained Earnings (Accumulated Deficit): $703 M (-6%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $37 M (-1%)
Stockholders' Equity (Parent): $1 B (0%)
Liabilities and Equity: $2 B (2%)
Revenue: $169 M (0%)
Cost of Revenue: $50 M (-45%)
Gross Margin: $119 M (-51%)
Research and Development: $30 M (-54%)
Restructuring Charges: $15 M (0%)
Operating Income/Loss: $6 M (-58%)
Income before taxes: $2 M (-88%)
Provision for income taxes: $1 M (-13%)
EPS (diluted): $0.01 (-90%)